NODE (groiN ultrasOunD cancEr)
Key facts
- Who runs it
- Queensland Centre for Gynaecological Cancer
- Where
- Australia5 sites in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 30 people, planned
- Started
- 1 Jul 2024
- Expected to end
- 31 Dec 2027
- Type of study
- Interventional, 3 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- High-resolution bilateral groin ultrasound surveillance
- Record updated
- 20 February 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
Show the full registry criteria (11)Hide the full registry criteria
Who can take part
- Women, over 18 years, with histologically confirmed SCC or adenocarcinoma of the vulva
- Clinically stage I or II on medical imaging (CT scan of pelvis, abdomen, and chest), without evidence of regional or distant metastatic disease
- Participant must be suitable to undergo IFL/SNB according to local clinical practice management guidelines
- Signed written informed consent
- Negative serum pregnancy test ≤ 30 days of surgery in pre-menopausal women and women < 2 years after the onset of menopause
- Patient lives within 40 km of a medical diagnostic imaging centre (site investigator approval required for special circumstances)
Who cannot take part
- Serious concomitant systemic disorders incompatible with the study (at the discretion of the investigator)
- Women with non-invasive vulvar conditions (e.g. non-invasive non-mammary Paget's disease)
- Clinical or medical imaging evidence of regional and/or distant metastatic disease
- Other prior malignancies <5 years before inclusion, except for successfully treated keratinocyte skin cancers, or ductal carcinoma in situ
- Estimated life expectancy of ≤6 months
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Sex
This trial is currently available in Australia.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study is an open label, prospective, experimental, randomised clinical trial. The primary aim of this study is to determine whether it is feasible to randomise vulvar cancer patients into one of two treatment arms:1) surgical groin node dissection (as delivered though either a sentinel node biopsy or inguinofemoral lymph node dissection (IFL), or 2) serial high-resolution bilateral groin ultrasound surveillance and clinical examination every 2 months for 12 months.
The 3 groups in the trial
- Participants with normal/negative baseline groin ultrasoundsTreatment being tested
Interventional Treatment: serial high-resolution bilateral groin ultrasound surveillance in conjunction with clinical examinations every 2 months (n=13).
Treatment: High-resolution bilateral groin ultrasound surveillance
- Participants with normal/negative baseline groin ultrasounds - Standard CareNo study treatment, for comparison
Standard Treatment: receive upfront full groin LND or sentinel node biopsy (SNB) based on clinician choice (according to local clinical practice management guidelines) (n=7).
- Participants with suspicious/indeterminate baseline groin ultrasoundNo study treatment, for comparison
Participants with suspicious/indeterminate baseline groin ultrasound (third group) will receive an upfront full groin LND or SNB, consistent with the current standard treatment, according to local clinical practice management guidelines (n=10).
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Randomised Feasibility Study of Groin Ultrasound Surveillance to De-Escalate Surgical Intervention in Women With Vulvar Cancer
- Criteria questions
- Built from NCT06264167, who can take part
- Record updated
- 20 February 2026